spacer
home > epc > winter 2003 > e-meetings and e-learning - how the internet can be harnessed to achieve efficiencies in clinical drug development
PUBLICATIONS
European Pharmaceutical Contractor

e-Meetings and e-Learning - How the Internet can be Harnessed to Achieve Efficiencies in Clinical Drug Development

Driven by a need to reduce drug development costs and speed new drugs to market in the most efficient manner possible, today's pharma industry is awash with cost containment measures. Senior executives continue the search for elusive efficiencies, ranging from the overnight closure of departments that were previously considered integral to a company's success to the imposition of strict new travel policies.

Few pharmaceutical companies or contract research organisations can have been immune to cost cutting in recent years and many have looked to the promise of technology to help them achieve their goals. Unfortunately, many technological advances require expensive re-engineering of traditional drug development processes, and while the long-term benefits of for example, electronic data capture (EDC) are likely to be sizeable, even when outsourced to a niche provider, EDC requires significant upfront investment in hardware and software as well as time-consuming re-writing of processes and associated training. A more modest approach involves combining readily available technology with small changes in process to produce an immediate impact on operational performance without the need for investment. When such small steps are applied consistently across an organisation, the benefits can be surprising.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Jane Baguley, Director at Cornaxis Ltd

With an Honours degree in Cell Sciences, Jane Baguley joined the pharmaceutical industry in 1988. After five years with Yamanouchi Pharma, Jane began a varied career at Quintiles encompassing both operational and business roles including clinical project management, medical writing, communication and strategy and business management. At the beginning of 2002, Jane set up Cornaxis Ltd to provide consultancy, strategic and operational services to the pharma industry. Cornaxis focuses on the use of novel technologies to support the attainment of cost efficiencies in the drug development process, while Jane maintains a particular interest in the challenge of patient recruitment.

spacer
Jane Baguley
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Vaisala Introduces CAB100 Industrial Cabinet for Cleanrooms

Vaisala, a global leader in weather, environmental, and industrial measurements, launches its newest offering for centralized environmental monitoring in cleanrooms: The CAB100 integrates Vaisala’s world-class instruments for monitoring parameters into a simple, pre-configured enclosure.
More info >>

White Papers

Advanced BioDesign Outlines Solutions

Advanced BioDesign

Launching an immunisation programme is an important experimental step that needs care. With Advanced BioDesign, clients may develop and produce antibodies according to customers' specific needs. The company offers: real support and advice from a dedicated team all along your project; large and modern SPF animal facility; ethical treatment of animals. The evaluation of a project is free-of-charge and with no obligation. Dedicated project managers will work with clients from the beginning to the end of a custom antibody project to ensure the highest level of quality and service.
More info >>

 
Industry Events

Nordic Life Science Days 10/12 September 2019

10-12 September 2019, Malmo Sweden

Nordic Life Science Days is the largest Nordic partnering conference for the global Life Science industry. Bringing together the best talents in Life Science, offering amazing networking and partnering opportunities, providing inputs and content on the most recent trends. Nordic Life Science Days attracts leading decision makers from the Life Science sector, not only from biotech, pharma and medtech but also from finances, research, policy and regulatory authorities.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement